$HTGM primed for $10+: STRONG BUY signal 700K float 500%+ Cost to Borrow $3M MC w/ $14M in cash Recent analyst targets of $15.00+ Excellent technical setup Also watching: $WISA $SLRX $GNUS

It’s not just the efficacy and safety of the product, it is the less cost for hospital/infusion, due to one hour infusion and the huge difference in price.

The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,

Each treatment cost under $10k per treatment.

Each treatment cost under $10k per treatment.

The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,

$HTGM primed for $10+: STRONG BUY signal 700K float 500%+ Cost to Borrow $3M MC w/ $14M in cash Recent analyst targets of $15.00+ Excellent technical setup Also watching: $WISA $SLRX $GNUS

🚨 $HTGM on Mega Watch 🚨 Innovative life science company with leading HTG platform (medicinal chemistry) tech: - 690K float - 900K outstanding - 550% Cost to Borrow (highest on market!)

$HTGM I love dollar cost averaging into a long term hold.

$HTGM shorts have been setup beautifully with 744 Cost to borrow 🤣🤣🤣🤣